FDA Approves Generic Abortion Pill Amid GOP Safety Concerns in US

The recent FDA approval of a generic form of mifepristone, a drug used in medication abortions, has sparked backlash from conservatives and anti-abortion activists, including calls from former Vice President Mike Pence for Health and Human Services Secretary Robert F. Kennedy Jr. to resign. The FDA defended the approval, stating it has limited discretion and must approve generics that demonstrate equivalence to brand-name drugs, a position supported by legal experts who warn against rejecting such applications on controversial grounds. In Nigeria, health experts and advocates are working to dispel myths about abortion's legality and safety, emphasizing that abortion is largely restricted by law and that safe procedures by medical professionals do not cause infertility. Meanwhile, U.S. health policy under the current administration has faced criticism for undermining scientific rigor, particularly concerning vaccine guidelines and controversial reviews of mifepristone despite its long-established safety record. The FDA and NIH also announced plans to reduce animal-based testing, a move that has generated mixed reactions including market impacts on related industries. Overall, these developments highlight ongoing tensions between political agendas, scientific evidence, and public health approaches to abortion and biomedical research.